Tissue Repair

Best Peptides for Wound Healing: Evidence-Based Guide

Guide to peptides for wound healing — BPC-157, GHK-Cu, and TB-500 with evidence, dosing, and wound care protocols.

Chronic wounds affect 6.5 million patients in the US annually; diabetic foot ulcers affect 15% of diabetics

This page is for educational purposes only and does not constitute medical advice. Peptides discussed are research compounds. Always consult a qualified healthcare provider for diagnosis and treatment.

Understanding Impaired Wound Healing

Impaired wound healing occurs when the normal healing cascade (hemostasis, inflammation, proliferation, remodeling) is disrupted. Common causes include diabetes, peripheral vascular disease, immunosuppression, malnutrition, and advanced age. Chronic wounds (diabetic ulcers, venous leg ulcers, pressure injuries) represent a significant healthcare burden.

Common Symptoms

Wounds that fail to heal within expected timeframes

Wound edges that do not progress

Chronic inflammation and exudate

Wound bed with poor granulation tissue

Recurrent wound breakdown

Conventional Treatments

Wound debridementMoist wound dressingsNegative pressure wound therapy (NPWT)Growth factor therapy (becaplermin/PDGF)Hyperbaric oxygen therapySkin grafting

How Peptides May Help

BPC-157 promotes angiogenesis, upregulates growth factor receptors, and accelerates wound closure in multiple animal models. GHK-Cu directly stimulates collagen synthesis and has demonstrated wound healing effects in human clinical studies. TB-500 promotes cell migration and tissue repair.

Top Peptides for Impaired Wound Healing

1GHK-Cu

Moderate — human clinical data for wound healing

Mechanism: Stimulates collagen synthesis, promotes angiogenesis, reduces inflammation, accelerates wound closure

Typical dose: Topical 1-5% applied to wound area; injectable 1-2mg SubQ near wound

2BPC-157

Strong preclinical; limited human data

Mechanism: Promotes angiogenesis, upregulates growth factor receptors, accelerates wound closure

Typical dose: 250-500mcg SubQ near wound, twice daily

3TB-500

Moderate preclinical

Mechanism: Promotes cell migration and actin polymerization; systemic tissue repair

Typical dose: 5-10mg/week SubQ loading phase

Suggested Starting Protocol

GHK-Cu topical 2% applied to wound area twice daily. BPC-157 250-500mcg SubQ near wound, twice daily. TB-500 5mg twice weekly for 4 weeks loading. Combine with standard wound care (debridement, appropriate dressings, infection management).

Important: Chronic wounds require medical management. Infection control and appropriate wound care are foundational. Peptides are experimental adjuncts — GHK-Cu has the most human evidence for wound healing. Diabetic wounds require blood glucose optimization as a priority.

Frequently Asked Questions

Can BPC-157 heal diabetic wounds?

BPC-157 has shown wound healing effects in diabetic animal models. Human clinical data is limited. Blood glucose control remains the most important intervention for diabetic wound healing.

How is GHK-Cu applied to wounds?

GHK-Cu can be applied topically as a 1-5% solution or cream directly to the wound bed. It can also be injected subcutaneously near (not into) the wound for combined local and systemic effects.

How long does peptide-assisted wound healing take?

Timeline depends on wound type and severity. Acute wounds may show accelerated healing within 1-2 weeks. Chronic wounds may require 4-12 weeks of consistent treatment.

Related Conditions

Tendinopathy (Tendon Injury)sports injury Skin Aging (Photoaging & Intrinsic Aging)Type 2 Diabetes

Find the right peptide for your biology

Take our 5-minute quiz to get a personalized peptide recommendation based on your specific goals and health profile.